ATS 2018 International Conference - Mobile

Targeting ENaC with an Epithelial RNAi Trigger Delivery Platform for the Treatment of Cystic Fibrosis [Board No. P960]

Location: Board no. P960

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Weijun Cheng

PhD
Arrowhead Pharmaceuticals

Holly Hamilton

PhD
Arrowhead Pharmaceuticals

Thomas Schluep

PhD
Arrowhead Pharmaceuticals

Ine Kuipers

PhD
Arrowhead Pharmaceuticals

Agnieszka Glebocka

PhD
Arrowhead Pharmaceuticals

Tao Pei

PhD
Arrowhead Pharmaceuticals

Zhen Li

PhD
Arrowhead Pharmaceuticals

Bo Chen

PhD
Arrowhead Pharmaceuticals

Rui Zhu

PhD
Arrowhead Pharmaceuticals

Erik Bush

PhD
Arrowhead Pharmaceuticals

Philip Kuehl

PhD
Lovelace Biomedical

Julia Hegge

PhD
Arrowhead Pharmaceuticals

View Abstract

Targeting ENaC with an Epithelial RNAi Trigger Delivery Platform for the Treatment of Cystic Fibrosis

Parent Sessions

B63 - INFLAMMATION AND CELLULAR RESPONSES IN CYSTIC FIBROSIS...
05-21-2018 9:15 AM - 4:15 PM